Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Forge Hydrocarbons is an industrial biotechnology company focused on the commercialization of Lipid-to-Hydrocarbon (LTH) technology. Developed at the University of Alberta, this proprietary process converts low-value bio-lipids, such as waste fats and greases, into drop-in renewable diesel and jet fuel. Unlike traditional biodiesel, the company's products are chemically identical to petroleum-based fuels, allowing for seamless integration into existing infrastructure without modification. Forge Hydrocarbons operates a commercial-scale production facility in Ontario, Canada, aiming to significantly reduce greenhouse gas emissions in the heavy-duty transportation and aviation sectors. The company is backed by strategic investors including Shell Ventures and focuses on sustainable, circular-economy solutions for the global energy industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Forge Hydrocarbons.